Collectively, these findings suggest that BCc1 may act as a dual-function nanomedicine, capable of modulating tumor-suppressive autophagy (via Beclin-1) while inhibiting pro-survival autophagy (via ATG-4B). This evidence concerns the gene ATG4B and neoplasm.